UK biotech boasts Europe's best pipeline as Brexit threat looms

LONDON (Reuters) - Britain's biotech sector boasts the strongest new drug pipeline in Europe but industry leaders say it needs continued access to global talent, funding and regulatory clarity to thrive in the future - all of which could be jeopardized by Brexit.